This story has been updated from an earlier version.
EHR giant Cerner and Amazon Web Services are in the late stages of talks about a partnership, sources told CNBC.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
AWS CEO Andy Jassy plans to announce the alliance during his November 29 keynote at re:Invest, according to the article.
By reportedly teaming up, the companies hope to focus on improving population health efforts. Sources told CNBC the partnership will initially revolve around HealtheIntent, Cerner’s population health offering. Through the product, hospitals can collect and analyze large volumes of data (including prescription information and data from EHRs) and use it to help patients and lower care costs.
The deal would give “big medical institutions access to the HealtheIntent analytics engine at AWS speed and scale and with additional artificial intelligence technologies,” according to the article. “For example, a hospital that wants to analyze the likely outcome of a group of people in Australia could quickly set up a HealtheIntent project because AWS has locations across the Asia-Pacific region.”
Amazon did not immediately respond to a request for comment. Via email, a Cerner spokesperson said the company doesn’t have any information to share at this time.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Amazon has been taking an interest in the healthcare sector for some time.
In fact, at re:Invest last year, a Cerner executive spoke about how HealtheIntent uses AWS for storage and disaster recovery.
This summer, a CNBC article claimed that Amazon has created a secret lab focused on EHRs and telemedicine. Additionally, reports that the company plans to break into the pharmacy sector were met with a variety of perspectives from industry experts. Together with numerous drugmakers, the tech giant also invested in Grail, Illumina’s diagnostics startup, at the beginning of this year.
Photo: MATJAZ SLANIC, Getty Images
